## **Core Concept**
Serotonin reuptake inhibitors are a class of drugs that block the reuptake of serotonin, a neurotransmitter, into the presynaptic neuron, thereby increasing its availability in the synaptic cleft. This mechanism is primarily utilized in the treatment of depression and anxiety disorders. The drugs in this class are known as selective serotonin reuptake inhibitors (SSRIs).

## **Why the Correct Answer is Right**
Mirtazapine is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). It works by antagonizing central presynaptic α2-adrenergic inhibitory autoreceptors and heteroreceptors, which increases the release of serotonin and norepinephrine. Unlike SSRIs, mirtazapine does not primarily act by inhibiting serotonin reuptake but rather through its antagonist effects on various receptors, including serotonin receptors.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Fluoxetine is a well-known SSRI, primarily used to treat depression, anxiety disorders, and some other conditions by inhibiting the reuptake of serotonin.
- **Option B:** Sertraline is another SSRI, similar to fluoxetine, used for treating depression, obsessive-compulsive disorder, panic disorder, and more by increasing serotonin levels in the brain.
- **Option D:** Paroxetine is also an SSRI, used in the treatment of major depressive disorder, anxiety disorders, and other conditions, functioning by inhibiting serotonin reuptake.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that while SSRIs are often considered first-line for depression and certain anxiety disorders due to their efficacy and safety profile, mirtazapine, with its unique mechanism, can be particularly useful in patients with depression who have significant insomnia or anorexia, as it can improve sleep and increase appetite.

## **Correct Answer:** . Mirtazapine